The role of Medical Affairs is evolving from reactive to proactive strategic partners and there is demand for securing support in building effective engagement and communication strategies.
Yet leading Medical Affairs teams continue to note that there here is a struggle right now to find a partner that has specialised knowledge in gene therapy to support in building and driving Medical Affairs launch plans.
The 2nd Annual Gene Therapy Medical Affairs Summit is set to unite global Medical Affairs leads from advancing gene therapy companies to explore how to optimise the role Medical Affairs plays in preparing for successful and patient-centric gene therapy launches.
From extensive research with these companies we are aware that they are all actively seeking to collaborate with organizations that can help them build and drive Medical Affairs launch strategies, reinforce communications and optimise KOL engagements.
If you are a solution provider with the knowledge and capabilities to meet this markets’ demands, then the 2nd Annual Gene Therapy Medical Affairs Summit will provide a platform for you to showcase your solutions to a niche audience of experts from the leading Medical Affairs teams.
Showcase your expertise to leading organizations by securing an exhibition booth
Secure a spot on our expert speaker faculty to demonstrate thought leadership and drive brand exposure
Maximize the balance of 2:1 live content and targeted networking to generate leads and build new relationships with gene therapy Medical Affairs pioneers
Meet your 2022 commercial objectives and educate decision-makers on how your expertise can deliver gene therapies to patients more effectively